Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia
| Autor: | Kerry Rodgers, Molly R. Hill, Stephen L. Clarke, Jeffrey M. Peters, Jeffrey M. Gimble, Brandi Thornhill, Frank J. Gonzalez |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Lipopolysaccharides
medicine.medical_specialty Lipopolysaccharide medicine.medical_treatment Immunology Population Receptors Cytoplasmic and Nuclear Alpha (ethology) Inflammation Biology Microbiology Mice chemistry.chemical_compound Fenofibrate Internal medicine medicine Animals Humans education Hypolipidemic Agents Mice Knockout Host Response and Inflammation education.field_of_study Tumor Necrosis Factor-alpha Endotoxemia Pyrimidines Infectious Diseases Endocrinology Cytokine chemistry Macrophages Peritoneal Peroxisome Proliferators Parasitology Tumor necrosis factor alpha Peroxisome proliferator-activated receptor alpha medicine.symptom Transcription Factors medicine.drug |
| Zdroj: | Infection and Immunity. 67:3488-3493 |
| ISSN: | 1098-5522 0019-9567 |
| DOI: | 10.1128/iai.67.7.3488-3493.1999 |
| Popis: | Inflammatory mediators orchestrate the host immune and metabolic response to acute bacterial infections and mediate the events leading to septic shock. Tumor necrosis factor (TNF) has long been identified as one of the proximal mediators of endotoxin action. Recent studies have implicated peroxisome proliferator-activated receptor alpha (PPARα) as a potential target to modulate regulation of the immune response. Since PPARα activators, which are hypolipidemic drugs, are being prescribed for a significant population of older patients, it is important to determine the impact of these drugs on the host response to acute inflammation. Therefore, we examined the role of PPARα activators on the regulation of TNF expression in a mouse model of endotoxemia. CD-1 mice treated with dietary fenofibrate or Wy-14,643 had fivefold-higher lipopolysaccharide (LPS)-induced TNF plasma levels than LPS-treated control-fed animals. Higher LPS-induced TNF levels in drug-fed animals were reflected physiologically in significantly lower glucose levels in plasma and a significantly lower 50% lethal dose than those in LPS-treated control-fed animals. Utilizing PPARα wild-type (WT) and knockout (KO) mice, we showed that the effect of fenofibrate on LPS-induced TNF expression was indeed mediated by PPARα. PPARα WT mice fed fenofibrate also had a fivefold increase in LPS-induced TNF levels in plasma compared to control-fed animals. However, LPS-induced TNF levels were significantly decreased and glucose levels in plasma were significantly increased in PPARα KO mice fed fenofibrate compared to those in control-fed animals. Data from peritoneal macrophage studies indicate that Wy-14,643 modestly decreased TNF expression in vitro. Similarly, overexpression of PPARα in 293T cells decreased activity of a human TNF promoter-luciferase construct. The results from these studies suggest that any anti-inflammatory activity of PPARα in vivo can be masked by other systemic effects of PPARα activators. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|